110 related articles for article (PubMed ID: 18261274)
1. [Mutation of the RET proto-oncogene in type 2A multiple endocrine neoplasia Chinese families and the application of pentagastrin stimulation test in diagnosis and follow-up].
Yao B; Liu X; Chen X; Dong TT; Liang H; Weng JP
Zhonghua Nei Ke Za Zhi; 2007 Nov; 46(11):914-8. PubMed ID: 18261274
[TBL] [Abstract][Full Text] [Related]
2. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
[TBL] [Abstract][Full Text] [Related]
3. [The clinical patterns and RET proto-oncogene in fifteen multiple endocrine neoplasia type 2A pedigrees].
Zhou YL; Zhu SX; Li JJ; Liu JB; Yin M; Xiao BY; Yu CL; Wang LM; Gu LQ; Cui B; Ning G; Li XY; Zhao YJ
Zhonghua Nei Ke Za Zhi; 2007 Jun; 46(6):466-70. PubMed ID: 17663821
[TBL] [Abstract][Full Text] [Related]
4. [DelD631: a novel mutation of the RET proto-oncogene in multiple endocrine neoplasia type 2A (MEN2A)].
Yao B; Liu X; Dong TT; Chen X; Huang ZM; Weng JP
Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(28):1962-5. PubMed ID: 17923033
[TBL] [Abstract][Full Text] [Related]
5. The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families.
Marsh DJ; McDowall D; Hyland VJ; Andrew SD; Schnitzler M; Gaskin EL; Nevell DF; Diamond T; Delbridge L; Clifton-Bligh P; Robinson BG
Clin Endocrinol (Oxf); 1996 Feb; 44(2):213-20. PubMed ID: 8849577
[TBL] [Abstract][Full Text] [Related]
6. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
[TBL] [Abstract][Full Text] [Related]
7. [Study of RET proto-oncogene mutations in two pedigrees affected with multiple endocrine neoplasia type 2A].
Weng Y; Li F; Zhang S; Cheng H; Yan L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Oct; 35(5):648-652. PubMed ID: 30298487
[TBL] [Abstract][Full Text] [Related]
8. A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families.
Marsh DJ; Robinson BG; Andrew S; Richardson AL; Pojer R; Schnitzler M; Mulligan LM; Hyland VJ
Genomics; 1994 Sep; 23(2):477-9. PubMed ID: 7835899
[TBL] [Abstract][Full Text] [Related]
9. [The clinical patterns and RET proto-oncogene identification of pheochromocytoma in 13 multiple endocrine neoplasia type 2A pedigrees].
Qi XP; Chen ZG; Jin HY; Li F; Cheng J; Ying RB; Zhao JQ; Guo DG; Luo SY; Chen GP; Zhang XN
Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(28):2200-4. PubMed ID: 24169328
[TBL] [Abstract][Full Text] [Related]
10. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of RET mutation screening in a pedigree of multiple endocrine neoplasia type 2A.
Ying R; Feng J
Mol Med Rep; 2016 Aug; 14(2):1413-7. PubMed ID: 27277749
[TBL] [Abstract][Full Text] [Related]
12. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A.
Lips CJ; Landsvater RM; Höppener JW; Geerdink RA; Blijham G; van Veen JM; van Gils AP; de Wit MJ; Zewald RA; Berends MJ
N Engl J Med; 1994 Sep; 331(13):828-35. PubMed ID: 7915822
[TBL] [Abstract][Full Text] [Related]
13. [RET gene cys 634 trp mutation in a multiple endocrine neoplasia type 2A kindred].
Ning ZW; Wang O; Pei Y; Meng XW; Xing XP; Xia WB; Li M; Zhou XY; Zeng ZP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Dec; 28(6):799-802. PubMed ID: 17260470
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features and mutations of RET proto-oncogene in a pedigree affected with type 2A multiple endocrine neoplasia].
Zhang Y; Zheng X; Cheng L; Ma S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):106-109. PubMed ID: 28186607
[TBL] [Abstract][Full Text] [Related]
15. [Phenotype of the C634Y mutation in the RET proto-oncogene in MEN2A: report of a family].
Sánchez Sobrino P; Páramo Fernández C; Gil Gil P; Mantiñán Gil B; Pérez Pedrosa A; Palmeiro Carballeira R; García-Mayor RV
Endocrinol Nutr; 2011 May; 58(5):229-35. PubMed ID: 21530422
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic correlation between RET proto-oncogene mutation, imaging techniques, biochemical markers and morphological examination in MEN2A syndrome: case report and literature review.
Sovrea AS; Dronca E; Galatâr M; Radian S; Vornicescu C; Georgescu C
Rom J Morphol Embryol; 2014; 55(2):389-400. PubMed ID: 24969991
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing for multiple endocrine neoplasia type 2.
Păun DL; Mohora M; Duţă C; Dumitrache C
Rom J Intern Med; 2008; 46(2):159-63. PubMed ID: 19284088
[TBL] [Abstract][Full Text] [Related]
18. A newly detected mutation of the RET protooncogene in exon 8 as a cause of multiple endocrine neoplasia type 2A.
Bethanis S; Koutsodontis G; Palouka T; Avgoustis C; Yannoukakos D; Bei T; Papadopoulos S; Linos D; Tsagarakis S
Hormones (Athens); 2007; 6(2):152-6. PubMed ID: 17704047
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of seven Mediterranean families with multiple endocrine neoplasia type 2A.
Oriola J; Hernandez C; Simo R; Barcelo A; Casamitjana R; Vilardell E; Rivera-Fillat F
Clin Endocrinol (Oxf); 1996 Feb; 44(2):207-12. PubMed ID: 8849576
[TBL] [Abstract][Full Text] [Related]
20. False-positive results of basal and pentagastrin-stimulated calcitonin in non-gene carriers of multiple endocrine neoplasia type 2A.
Hernández G; Simó R; Oriola J; Mesa J
Thyroid; 1997 Feb; 7(1):51-4. PubMed ID: 9086571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
